CVIA Journal

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the World Heart Federation (WHF) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Diastolic Function: the Importance of Untwisting and Suction in Diastolic Filling

Presenter: John E. Sanderson, MA MD FRCP

Professor Sanderson discusses how:

• Untwisting with recoil causes suction which is responsible for pulling the blood into the ventricle during early diastole.
• The extent and speed of the recoil and hence suction depend on the force of the previous systolic contraction and the amount of stored energy, rate of myocyte relaxation, state of titins within the myocyte and the quality of the extracellular matrix.
• Reduced suction, and hence reduced early diastolic filling is found in nearly all forms of heart failure and is associated with normal aging. Exercise may slow the rate of reduction.
• Improving this fundamental property of the heart as a suction pump will require sophisticated therapy.
• Systole and diastole are intimately connected and there is in essence one cardiac cycle. Isolated diastolic dysfunction is extremely rare.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Imaging

Presenter: Victoria Delgado, MD, PhD, FESC, Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

In this presentation Professor Delgado discusses:

• Further evidence on CAD
• Aortic pathology
• Characterizing LV mechanics
• Myocardial fibrosis imaging

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

GW-ICC Pre-Registration Ends 20^th August 2018

Don’t Miss this Opportunity to Enjoy Discounted (Up To 25%) Registration Fees

The 29^th Great Wall International Congress of Cardiology (GW-ICC) takes place from 11^th -14^th October 2018 in Beijing, China.

The conference is jointly hosted by more than twenty Chinese and international cardiovascular organizations covering thirteen academic fields over sixty areas of expertise; and will include more than 400 seminars, training workshops, exhibitions and joint forums that are hosted in conjunction with respected international cardiology associations.

The conference will welcome more than one thousand international delegates from over forty countries; over two thousand Chinese cardiologists and over seventeen thousand other delegates who will share and learn from cutting edge research and innovation in cardiology and related fields.

Opening Ceremony: Keynote Presentations

At the opening ceremony, the following distinguished speakers will deliver keynote presentations:

Building Regional Systems of care for STEMI–how can we improve?

Michael Valentine, MD, FACC, ACC President

Dr. Valentine is a senior cardiologist at the Stroobants Cardiovascular Center of Centra Health in Lynchburg, Virginia, USA and has previously served on the ACC’s board of trustees and advocacy committee and as the Virginia chapter governor and board of governors’ chair. He graduated from the University of Virginia School of Medicine. Dr. Valentine has special training and interest in pacing, electrophysiology and interventional cardiology.

New therapeutic targets in atrial fibrillation

Barbara Casadei, MD DPhil FRCP FMedSci FESC, President Elect of the European Society of Cardiology

Professor Casadei is currently Deputy Head of Division of Cardiovascular Medicine in Oxford. Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme focussed on atrial fibrillation, which spans from clinical trials to bench-based investigation in human tissue and cells.

Atrial Fibrillation: Global Challenges and Opportunities

Ivor J. Benjamin, MD, FACC, FAHA, President Elect of the AHA

Dr. Ivor J. Benjamin, is currently professor of medicine and director of the Cardiovascular Center at Froedtert Hospital and the Medical College of Wisconsin, USA. Dr Benjamin received his medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years.

The global challenge of heart attacks and strokes – resolve to treat hypertension

David Wood, MB ChB, MSc, FRCP, FRCPE, FFPHM, FESC, President World Heart Federation

Professor Wood is currently Garfield Weston Professor of Cardiovascular Medicine and Honorary Consultant Cardiologist, National Heart and Lung Institute, Imperial College London, United Kingdom. Professor Wood has contributed to international policy and guidelines on cardiovascular disease (CVD) prevention through the World Health Organization, World Heart Federation and the European Society of Cardiology. He was a founder and President of the European Association for Cardiovascular Prevention and Rehabilitation and a Board member of the European Society of Cardiology.

New Frontiers in Health: The Heart and The Brain

Valentin Fuster, MD, PhD, Editor-in-Chief of Journal of the American College of Cardiology

After qualifying in medicine at the University of Barcelona, Dr Fuster continued his studies in the United States. Currently he serves The Mount Sinai Medical Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health and is CEO of the National Center for Cardiovascular Research (CNIC). He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai. Dr Fuster has made significant contributions throughout his professional career to the advancement of cardiology research, the prevention and treatment of cardiovascular disease, particularly coronary artery disease, atherosclerosis and thrombosis.

Cardiovascular Disease: Yesterday, Today, and Tomorrow

Joseph Hill, MD, PhD, Editor-in-Chief of Circulation

Dr Joseph Hill is Chief of UT Southwestern Medical Center’s Division of Cardiology and Director of the Harry S. Moss Heart Center, Dallas, TX, USA. Dr Hill’s research focuses on molecular mechanisms of structural, functional, and electrophysiological remodeling in cardiac hypertrophy and heart failure. He earned his medical and doctoral (pharmacology) degrees at Duke University, completed fellowships with the Institut Pasteur in Paris and the Brigham and Women’s Hospital, Harvard Medical School.

Acute Coronary Syndromes: What we have achieved, what remains to be don

Thomas F. Lüscher, M.D., F.R.C.P., Editor-in-Chief of European Heart Journal

Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College, London, United Kingdom and Director of the Center for Molecular Cardiology at the University Zurich, Switzerland. Professor Lüscher is a board certified internist and cardiologist with training in internal medicine at the University Hospital Zurich, cardiovascular physiology and cardiology at the Mayo Clinic, Rochester, MN, USA and in cardiology and clinical pharmacology at the University Hospital Basel, Switzerland. Prior to his current position he was Professor of Pharmacotherapy at the University of Basel, then Professor and vice-chairman of cardiology at the Inselspital of the University of Berne, Switzerland.

Further information on the 29th GW-ICC, to be held 11th -14th October, 2018, in Beijing, China, is available on the congress website:

www.gw-icc2018.org

Email: secretariat@cardiounion.cn

About Beijing

Beijing, the capital of China, features modern architecture, infrastructure and technology alongside historic landmarks and monuments, set against traditions and a culture that evolved from 5,000 years of civilization. From the world famous Olympic Bird’s Nest Stadium (China National Stadium) to the Forbidden City, Beijing has a wealth of treasures for you to discover.

We look forward to welcoming you to Beijing!

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

SCAI @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) – CTO PCI Technique and Clinical Update

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Society for Cardiovascular Angiography and Interventions (SCAI) held a Joint Forum. A video of one of these 2017 sessions, Challenges of Chronic Total Occlusion, is now available to view on the GW-ICC YouTube channel:

CTO PCI Technique and Clinical Update

Presenter: – Jonathan Hill, Consultant Cardiologist, London Bridge Hospital, King’s College Hospital, London, United Kingdom

Dr Hill discusses:

• How advanced CTO PCI techniques drive expansion of complex techniques and increase rates of complete vascularization.
• Advanced CTO PCI techniques and LC Support
• Achieving near complete revascularization should be the aim of all CTO and complex PCI procedures.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the AHA @ GW-ICC Joint Forum, which was held over three sessions, focused on population health, guidelines and real-world evidence; cardiovascular disease prevention: hypertension, smoking cessation and blood lipid management and systems of STEMI care.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Applying Evidence Based Guidelines to Improve Cardiovascular Disease Outcomes

Presenter: Sidney C. Smith, Jr., MD, FAHA, FESC, FACP, MACC, Professor of Medicine and Director of the Center for Cardiovascular Science and Medicine at the University of North Carolina, Chapel Hill, NC, USA.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ACC @ GW-ICC Joint Forum, which was held over three sessions, focused on population health, guidelines and real-world evidence; cardiovascular disease prevention: hypertension, smoking cessation and blood lipid management and systems of STEMI care.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Non-Statin Therapy- What is the Evidence and When Do We Use Them?

Presenter: Christie M. Ballantyne, Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart & Vascular Center, Baylor College of Medicine, Houston, TX, USA.

Dr Ballantyne discusses how:

• Evidence from clinical trials have conclusively shown the benefit of aggressive lowering of LDL-C in high risk individuals and all guidelines recommend initial therapy with statins.
• Asian patients must be included in clinical trials for lipid therapy as both risks and benefits have been shown to be different than western populations (i.e. statins and niacin)
• Nonstatin therapies (ezetimibe, PSCK9 inhibitors and anacetrabib) have now been shown to reduce CVD events when added to statin therapies consistent with the amount of LDL-C reduction and with safety data in Asian patients.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the World Heart Federation (WHF) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Roadmaps: What, When, Where, Why, and How?

Presenter: Daniel José Piñeiro, Professor of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina.

Professor Piñeiro discusses how the World Heart Federation has undertaken an initiative to develop a series of Roadmaps, such as The World Heart Federation Roadmap for NonValvular Atrial Fibrillation, to promote development of national policies and health systems approaches, and to identify potential roadblocks on the road to effective prevention, detection, and management of cardiovascular disease in low-and middle-income countries (LMICs) and develop strategies for overcoming these.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Turkish Society of Cardiology (TAS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Statins 2017 Pitavastatin

Presenter: Meral Kayıkcıoğlu, Ege University Medical School, Izmir, Turkey.

In this presentation Professor Kayıkcıoğlu reviews Pitavastatin:

• Pitavastatin has a novel structure compared to other statins
• The cyclopropyl side chain:
  • Allows tight binding to HMG-CoA reductase
  • Diverts metabolism away from CYP3A4 through which many other drugs are metabolised
  • May reduce the extent of pitavastatin metabolism
• Overall safety profile is typical of the class
• Post marketing data from Japan shows a comparable muscle ADR to low dose simvastatin
  • Has pleiotropic effects
  • Effect on HDL-C is remarkable
  • With high safety

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Society for Cardiovascular Angiography and Interventions (SCAI) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Tips and Tricks of Atherectomy

Presenter: -Arthur Lee, Professor of Cardiology, California NorthState University, CA, USA.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp